APA (7th ed.) Citation

Li, C., Liu, J., Wang, L., & Xiong, W. (2025). Mechanisms for fibrate lipid-lowering drugs in enhancing bladder cancer immunotherapy by inhibiting CD276 expression. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14855-w

Chicago Style (17th ed.) Citation

Li, Cheng, Jiahao Liu, Long Wang, and Wei Xiong. "Mechanisms for Fibrate Lipid-lowering Drugs in Enhancing Bladder Cancer Immunotherapy by Inhibiting CD276 Expression." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14855-w.

MLA (9th ed.) Citation

Li, Cheng, et al. "Mechanisms for Fibrate Lipid-lowering Drugs in Enhancing Bladder Cancer Immunotherapy by Inhibiting CD276 Expression." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14855-w.